Atherosclerosis Plus · 2022 · 10 citations · 29 references
MedicineCardiologyImmunologyAutoimmunityImmunopathologyInflammationCardiovascular DiseaseCoronary Artery DiseaseFamilial HypercholesterolemiaInflammatory BiomarkersLipid DisordersLipid-lowering TherapyAtherosclerosis RiskAtherosclerotic Lipid AccumulationAtherosclerotic Risk AssessmentComputed Tomography Coronary AngiographyCoronary Artery Calcium ScoreDisease Severity EstimationImmune System BiomarkersInflammation In Cardiovascular Disease
Background and aims: Familial hypercholesterolemia (FH) is characterized by lifelong exposure to high LDL-c concentrations and premature atherosclerotic cardiovascular disease; nevertheless, disease severity can be heterogeneous.We aimed at evaluating if the immune-inflammatory system could modulate atherosclerosis burden in FH. Methods: -ApoB-D) autoantibodies (IgM and IgG), lymphocytes subtypes, platelet, monocyte and endothelial microparticles (MP), IgM levels (circulating or produced by B1 cells) and cytokines in the supernatant of cultured cells were determined. Multiple linear regression models evaluated associations of these biomarkers with CAC and CAD-RADS scores. Results: = 0.049; 95% CI for B 0.000 to 0.053) was independent predictor. Conclusions: In subjects with FH, under high-intensity lipid-lowering therapy, age and CD4+T cells were associated to atherosclerosis burden.
29
Børge G. Nordestgaard, M. John Chapman, Steve E. Humphries et al. · European Heart Journal · 2013 · 2.7K citations · Full text
Ricardo C. Cury, Suhny Abbara, Stephan Achenbach et al. · Journal of cardiovascular computed tomography · 2016 · 650 citations · Full text
Medicine, Cardiology, Radiology +17